9 February 2021

Effective 1 January, 2021, internist Saskia Middeldorp has been appointed Professor of Internal Medicine at Radboud University/Radboudumc. This chair is part of the position of Head of the Department of Internal Medicine that she has held since 1 January 2021.

In her position as professor and department head, Saskia Middeldorp sees it as her mission to monitor and shape the balance between the role of generalist on the one hand and the role of expert on the other. She explains: "Internal medicine has developed enormously with innovations in terms of diagnostic and therapeutic modalities in recent decades. In addition to their in-depth expertise, internists continue to play a leading role in providing optimal patient care, scientific research and training, thus realizing personalized care that does justice to the Radboudumc mission 'to have a significant impact on healthcare'. She also aims to attract and retain top academic talent and continues to stimulate the department's leading clinical and translational research.

Thrombosis and thrombophilia

Saskia Middeldorp will also continue her own research into thrombosis in special patient groups. Already during her PhD she investigated the impact of hereditary thrombophilia and the influence of oral contraceptives on blood coagulation and thrombosis risk. In the following years, she further specialized in vascular medicine and in particular in thrombosis and thrombophilia, with a special focus on women. In 2012, she received a VIDI grant.

Vascular medicine

Saskia Middeldorp (1966, Amsterdam) was trained as a physician and internist in Amsterdam, where she also received her PhD in thrombosis and thrombophilia. After her training as an internist, she continued her career as a staff member at the AMC. From 2006 to July 2010, she worked at Leiden University Medical Center. In 2010 Saskia Middeldorp returned to Amsterdam and was appointed Professor of Internal Medicine at the AMC. She became co-head of the Department of Vascular Medicine, chaired the residency program in Vascular Medicine, and led the research lines in the field of Thrombosis and Hemostasis.

Photograpy: Simon Warmer.

  • Want to know more about these subjects? Click on the buttons below for more news.

    RIHSInternal Medicine

Related news items


Tailored drug dosage for pregnant women

14 March 2022 Three quarters of women in the Netherlands use some form of medication during pregnancy, but little is known about the appropriate dosages. Research by the Radboudumc, MUMC+ and Lareb Mothers of Tomorrow should change this. read more

Q fever antibody does not predict disease progression

6 July 2021 Joint study by Radboudumc, Jeroen Bosch Hospital and UMC Utrecht. read more

First Dutch professor of infectious disease outbreaks at Radboud university medical center

4 June 2021 Chantal Bleeker-Rovers about research on coronavirus, Q fever and other infectious diseases outbreaks read more

First volunteers vaccinated with Radboudumc malaria vaccine

20 May 2021 Today a new vaccine against malaria, largely developed in Nijmegen, is being tested for the first time in volunteers at Radboudumc. read more

COVID-19 associated coagulopathy - lessons after 1 year

17 May 2021 Jenneke Leentjens, Saskia Middeldorp, and colleagues, published a review on the current knowledge of COVID-19 associated coagulopathy and the role of antithrombotic therapies in the Lancet Haematology. read more

Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection

17 February 2021 In a review in Cell Mihai Netea, Frank van de Veerdonk, Reinout van Crevel and Jorge Dominguez Andres propose that induction of trained immunity by whole-microorganism vaccines may represent an important tool for reducing susceptibility to and severity of SARS-CoV-2. read more